Boston Scientific Inks Smart Therapeutics Deal, Closes On Radiotherapeutics
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific plans to combine its GDC aneurysm coils with Smart Therapeutics, Inc.'s development-phase intracranial stent system to better treat intracranial aneurysmal disease under a definitive acquisition agreement, announced Dec. 13